SCHEMBL14917828

SCHEMBL14917828

CSCCC(NC(=O)OC(C)(C)C)C(=O)NC1CCN(c2nc(C(C)C)ns2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.45
CTSS P25774 1/20 0.43
CTSK P43235 1/20 0.43
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
POLB P06746 1/20 0.42
KLK5 Q9Y337 1/20 0.41
SUV39H2 Q9H5I1 2/20 0.39
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
CA2 P00918 1/20 0.38
HRH2 P25021 2/20 0.38
HRH1 P35367 2/20 0.38
HPGD P15428 2/20 0.37
LMNA P02545 1/20 0.37
THRB P10828 1/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14917830 1.00 TSHR (0.45) TSHRCTSSCTSKHDAC4HDAC1
SCHEMBL14918561 0.88 L3MBTL1 (0.41) TSHRALDH1A1MAPTL3MBTL1LMNA
SCHEMBL14918868 0.82 CKS1B (0.47) CTSKSUV39H2CA2
SCHEMBL789305 0.77 CTSS (0.56) TSHRCTSSCTSKHDAC4HDAC1
SCHEMBL31291788 0.77 HDAC4 (0.63) TSHRCTSSCTSKHDAC4HDAC1
SCHEMBL2597171 0.77 KLK5 (0.44) TSHRCTSSCTSKHDAC4HDAC1
SCHEMBL2597172 0.77 KLK5 (0.44) TSHRCTSSCTSKHDAC4HDAC1
SCHEMBL6207008 0.76 HDAC4 (0.68) TSHRCTSSCTSKHDAC4HDAC1
SCHEMBL5218978 0.76 HDAC4 (0.68) TSHRCTSSCTSKHDAC4HDAC1
SCHEMBL29894687 0.76 CTSS (0.43) TSHRCTSSCTSKHDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256756-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS ARRAY BIOPHARMA, INC. 2014-09-11 US disclosed
WO-2013066869-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS ARRAY BIOPHARMA INC. (US) 2013-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256756-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS GPR119, GPR139, GLP1R TSHR 746/4885CTSS 1541/4885CTSK 2901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.